No headlines found.
Globe Newswire (Mon, 27-Jul 8:00 AM ET)
Fortress Biotech to Participate in A.G.P.'s Annual Virtual Healthcare Conference
Globe Newswire (Mon, 18-May 8:30 AM ET)
Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Globe Newswire (Thu, 14-May 4:10 PM ET)
Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
Globe Newswire (Mon, 4-May 8:30 AM ET)
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock trades on the NASDAQ stock market under the symbol FBIOP.
As of July 28, 2026, FBIOP stock price declined to $18.76 with 8,630 million shares trading.
FBIOP has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, FBIOP traded as high as $21.43 and as low as $4.72.
FBIOP has outperformed the market in the last year with a price return of +164.2% while the SPY ETF gained +17.5%. FBIOP has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +29.4% and +0.3%, respectively, while the SPY returned +3.9% and -1.1%, respectively.
FBIOP support price is $18.39 and resistance is $19.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FBIOP shares will trade within this expected range on the day.
